Lumexa Imaging Holdings, Inc. Proceeds from Lines of Credit
Lumexa Imaging Holdings, Inc. (LMRI) reported Proceeds from Lines of Credit of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2026-08-13
- 2026-06-30: Proceeds from Lines of Credit 6 month $0.00.
- 2025-06-30: Proceeds from Lines of Credit 6 month $5.00M.
| Period end | Proceeds from Lines of Credit 6 month |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 |
| 2025-06-30 | $5.00M 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B |